Knoa Pharma: Chronic Pain trials
The registry lists 12 Chronic Pain studies with Knoa Pharma as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 3 11No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health SystemCompletedNCT03299556Results posted
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back PainCompletedNCT01358526Phase 3Results posted
- Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of KneeCompletedNCT00531427Phase 3Results posted
- Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back PainCompletedNCT00490919Phase 3Results posted
- Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.TerminatedNCT00320801Phase 3Results posted
- Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or KneeCompletedNCT00313846Phase 3Results posted
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant PainCompletedNCT00312195Phase 3Results posted
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back PainCompletedNCT01427283Phase 3
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back PainCompletedNCT01427270Phase 3
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.CompletedNCT00315848Phase 3
- Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.CompletedNCT00314652Phase 3
- Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.CompletedNCT00313833Phase 3